On Monday, Oncology Institute Inc (NASDAQ: TOI) opened lower -8.44% from the last session, before settling in for the closing price of $3.79. Price fluctuations for TOI have ranged from $0.13 to $4.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -488.57% over the last five years. Company’s average yearly earnings per share was noted 23.00% at the time writing. With a float of $46.22 million, this company’s outstanding shares have now reached $93.28 million.
The firm has a total of 825 workers. Let’s measure their productivity.
Oncology Institute Inc (TOI) Insider Activity
A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of Oncology Institute Inc is 50.57%, while institutional ownership is 27.86%. The most recent insider transaction that took place on Aug 19 ’25, was worth 82,097. In this transaction Director of this company sold 20,221 shares at a rate of $4.06, taking the stock ownership to the 622,980 shares. Before that another transaction happened on Jun 05 ’25, when Company’s Director sold 673,676 for $3.05, making the entire transaction worth $2,054,712. This insider now owns 13,950,557 shares in total.
Oncology Institute Inc (TOI) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.00% per share during the next fiscal year.
Oncology Institute Inc (NASDAQ: TOI) Trading Performance Indicators
Check out the current performance indicators for Oncology Institute Inc (TOI). In the past quarter, the stock posted a quick ratio of 1.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.68, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of Oncology Institute Inc (TOI)
Analysing the last 5-days average volume posted by the [Oncology Institute Inc, TOI], we can find that recorded value of 1.53 million was better than the volume posted last year of 1.48 million. As of the previous 9 days, the stock’s Stochastic %D was 19.57%.
During the past 100 days, Oncology Institute Inc’s (TOI) raw stochastic average was set at 70.32%, which indicates a significant increase from 0.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.32 in the past 14 days, which was higher than the 0.32 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.24, while its 200-day Moving Average is $1.73. Now, the first resistance to watch is $3.67. This is followed by the second major resistance level at $3.88. The third major resistance level sits at $3.98. If the price goes on to break the first support level at $3.36, it is likely to go to the next support level at $3.26. Should the price break the second support level, the third support level stands at $3.05.
Oncology Institute Inc (NASDAQ: TOI) Key Stats
There are currently 89,234K shares outstanding in the company with a market cap of 324.45 million. Presently, the company’s annual sales total 393,410 K according to its annual income of -64,660 K. Last quarter, the company’s sales amounted to 119,800 K and its income totaled -17,010 K.
